On March 22, 2024, Sariel Diagnostics Corp., closed the transaction. The company received a private placement of 3,750,000 common shares will issue at price of CAD 0.02 per share for gross proceeds of CAD 75,000. No commission or finders?

fees were paid in connection with the Private Placement. All securities issued and issuable in connection with the Private Placement are subject to a statutory hold period expiring on July 23, 2024.